Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms-the Beyond Ageing Project: a randomized controlled trial

被引:104
作者
Walker, Janine G. [1 ]
Batterham, Philip J. [1 ]
Mackinnon, Andrew J. [2 ,3 ]
Jorm, Anthony F. [2 ,3 ]
Hickie, Ian [4 ,5 ]
Fenech, Michael [6 ]
Kljakovic, Marjan [7 ]
Crisp, Dimity [1 ]
Christensen, Helen [1 ]
机构
[1] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia
[2] ORYGEN Youth Hlth, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Brain & Mind Res Inst, Sydney, NSW, Australia
[5] Univ Sydney, Sydney, NSW 2006, Australia
[6] Commonwealth Sci & Ind Res Org, Nutrigen & Genome Hlth Lab, Adelaide, SA, Australia
[7] Australian Natl Univ, Acad Unit Gen Practice & Community Hlth, Sch Med, Canberra, ACT, Australia
基金
英国医学研究理事会;
关键词
INFORMANT QUESTIONNAIRE; PLASMA HOMOCYSTEINE; ALZHEIMER-DISEASE; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; ELDERLY IQCODE; DOUBLE-BLIND; TICS-M; IMPAIRMENT; PERFORMANCE;
D O I
10.3945/ajcn.110.007799
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Evidence remains unclear as to whether folic acid (FA) and vitamin B-12 supplementation is effective in reducing depressive symptoms. Objectives: The objective was to determine whether oral FA + vitamin B-12 supplementation prevented cognitive decline in a cohort of community-dwelling older adults with elevated psychological distress. Design: A randomized controlled trial (RCT) with a completely crossed 2 x 2 x 2 factorial design comprising daily oral 400 mu g FA + 100 mu g vitamin B-12 supplementation (compared with placebo), physical activity promotion, and depression literacy with comparator control interventions for reducing depressive symptoms was conducted in 900 adults aged 60-74 y with elevated psychological distress (Kessler Distress 10-Scale; scores >15). The 2-y intervention was delivered in 10 modules via mail with concurrent telephone tracking calls. Main outcome measures examined change in cognitive functioning at 12 and 24 mo by using the Telephone Interview for Cognitive Status-Modified (TICS-M) and the Brief Test of Adult Cognition by Telephone (processing speed); the Informant Questionnaire on Cognitive Decline in the Elderly was administered at 24 mo. Results: FA + vitamin B-12 improved the TICS-M total (P = 0.032; effect size d = 0.17), TICS-M immediate (P = 0.046; d = 0.15), and TICS-M delayed recall (P = 0.013; effect size d = 0.18) scores at 24 mo in comparison with placebo. No significant changes were evident in orientation, attention, semantic memory, processing speed, or informant reports. Conclusion: Long-term supplementation of daily oral 400 mu g FA + 100 mu g vitamin B-12 promotes improvement in cognitive functioning after 24 mo, particularly in immediate and delayed memory performance. This trial was registered at clinicaltrials.gov as NCT00214682. Am J Clin Nutr 2012;95:194-203.
引用
收藏
页码:194 / 203
页数:10
相关论文
共 51 条
[1]   High-dose B vitamin supplementation and cognitive decline in Alzheimer disease - A randomized controlled trial [J].
Aisen, Paul S. ;
Schneider, Lon S. ;
Sano, Mary ;
Diaz-Arrastia, Ramon ;
van Dyck, Christopher H. ;
Weiner, Myron F. ;
Bottiglieri, Teodoro ;
Jin, Shelia ;
Stokes, Karen T. ;
Thomas, Ronald G. ;
Thal, Leon J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (15) :1774-1783
[2]   Interpreting scores on the Kessler Psychological Distress Scale (K10) [J].
Andrews, G ;
Slade, T .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2001, 25 (06) :494-497
[3]   Disability and mild cognitive impairment: A longitudinal population-based study [J].
Artero, S ;
Touchon, J ;
Ritchie, K .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2001, 16 (11) :1092-1097
[4]  
Australian Bureau of Statistics, 2003, INF PAP US KESSL PSY
[5]   Vitamin B6, B12, and folic acid supplementation and cognitive function -: A systematic review of randomized trials [J].
Balk, Ethan M. ;
Raman, Gowri ;
Tatsioni, Athina ;
Chung, Mei ;
Lau, Joseph ;
Rosenberg, Irwin H. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (01) :21-30
[6]   Depressive symptoms, vascular disease, and mild cognitive impairment - Findings from the cardiovascular health study [J].
Barnes, DE ;
Alexopoulos, GS ;
Lopez, OL ;
Williamson, JD ;
Yaffe, K .
ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (03) :273-280
[7]   Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria - Results of the Leipzig Longitudinal Study of the Aged (LEILA75+) [J].
Busse, A ;
Bischkopf, J ;
Riedel-Heller, SG ;
Angermeyer, MC .
BRITISH JOURNAL OF PSYCHIATRY, 2003, 182 :449-454
[8]   Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh compound-B [J].
Butters, Meryl A. ;
Klunk, William E. ;
Mathis, Chester A. ;
Price, Julie C. ;
Ziolko, Scott K. ;
Hoge, Jessica A. ;
Tsopelas, Nichoias D. ;
Lopresti, Brian J. ;
Reynolds, Charles F., III ;
DeKosky, Steven T. ;
Meltzer, Carolyn C. .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2008, 22 (03) :261-268
[9]  
CHRISTENSEN H, 1992, ACTA PSYCHIAT SCAND, V85, P105
[10]   Folic acid for the prevention of colorectal adenomas - A randomized clinical trial [J].
Cole, Bernard F. ;
Baron, John A. ;
Sandler, Robert S. ;
Haile, Robert W. ;
Ahnen, Dennis J. ;
Bresalier, Robert S. ;
McKeown-Eyssen, Gail ;
Summers, Robert W. ;
Rothstein, Richard I. ;
Burke, Carol A. ;
Snover, Dale C. ;
Church, Timothy R. ;
Allen, John I. ;
Robertson, Douglas J. ;
Beck, Gerald J. ;
Bond, John H. ;
Byers, Tim ;
Mandel, Jack S. ;
Mott, Leila A. ;
Pearson, Loretta H. ;
Barry, Elizabeth L. ;
Rees, Judy R. ;
Marcon, Norman ;
Saibil, Fred ;
Ueland, Per Magne ;
Greenberg, E. Robert .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (21) :2351-2359